- Home
- AMPS vs EYPT Comparison
AMPS vs EYPT Comparison
Compare AMPS & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMPS
- EYPT
- Stock Information
- Founded
- AMPS 2009
- EYPT 1987
- Country
- AMPS United States
- EYPT United States
- Employees
- AMPS N/A
- EYPT N/A
- Industry
- AMPS Electric Utilities: Central
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- AMPS Utilities
- EYPT Industrials
- Exchange
- AMPS Nasdaq
- EYPT Nasdaq
- Market Cap
- AMPS 608.0M
- EYPT 489.4M
- IPO Year
- AMPS N/A
- EYPT 2005
- Fundamental
- Price
- AMPS $3.96
- EYPT $7.69
- Analyst Decision
- AMPS Strong Buy
- EYPT Strong Buy
- Analyst Count
- AMPS 9
- EYPT 8
- Target Price
- AMPS $5.38
- EYPT $25.71
- AVG Volume (30 Days)
- AMPS 1.1M
- EYPT 665.0K
- Earning Date
- AMPS 03-13-2025
- EYPT 03-06-2025
- Dividend Yield
- AMPS N/A
- EYPT N/A
- EPS Growth
- AMPS N/A
- EYPT N/A
- EPS
- AMPS 0.22
- EYPT N/A
- Revenue
- AMPS $185,992,000.00
- EYPT $45,713,000.00
- Revenue This Year
- AMPS $30.74
- EYPT N/A
- Revenue Next Year
- AMPS $17.00
- EYPT N/A
- P/E Ratio
- AMPS $17.86
- EYPT N/A
- Revenue Growth
- AMPS 25.90
- EYPT 7.50
- 52 Week Low
- AMPS $2.71
- EYPT $6.90
- 52 Week High
- AMPS $7.28
- EYPT $30.99
- Technical
- Relative Strength Index (RSI)
- AMPS 51.87
- EYPT 41.66
- Support Level
- AMPS $3.60
- EYPT $7.58
- Resistance Level
- AMPS $4.14
- EYPT $8.16
- Average True Range (ATR)
- AMPS 0.26
- EYPT 0.55
- MACD
- AMPS 0.02
- EYPT -0.07
- Stochastic Oscillator
- AMPS 70.53
- EYPT 3.06
About AMPS Altus Power Inc.
Altus Power Inc is a developer, owner, and operator of large-scale photovoltaic and energy storage systems across the United States. The company serve commercial, industrial, public sector, and community solar customers. Its mission is to drive the clean energy transition by developing and operating solar generation and energy storage facilities. It owns a diverse portfolio of solar PV systems and has long-term agreements with enterprise entities and residential customers. Their primary product offerings include leases and revenue contracts for solar power generation, alongside electric vehicle charging and energy storage solutions. Revenue streams include power purchase agreements, net metering credit agreements, and SREC revenue.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.